Bosulif and Pfizer
By slowing down or stopping the production of abnormal blood cells, Bosulif® (bosutinib) can help treat a certain type of leukemia in adults. This prescription medicine comes as a tablet and is taken once a day. It is specifically designed to treat a specific type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia. It is used when other treatment has failed or cannot be tolerated.
Bosulif is made by Pfizer Labs. It is only available in brand-name form at this time, as patents currently prevent any company from making a generic version of this drug.
(Click Bosulif to read the full-length overview of this chemotherapy drug.)